Abstract
Eye movements are an important aspect of neurological clinical assessment, as abnormal eye movements can indicate underlying neurological and disease processes. Eye-tracking recordings are also often performed following neurological injury or disease in order to study the underlying neurological mechanisms involved in controlling eye movement. The present chapter will review some major neurological conditions (Parkinson’s disease, Huntington’s disease, dementia, stroke, multiple sclerosis, and traumatic brain injury) that impact eye movements and the abnormalities that accompany them. The subjective clinical and objective examinations of eye movements are discussed and described in relation to neurological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leat SJ et al (2013) Binocular vision and eye movement disorders in older adults. Invest Ophthalmol Vis Sci 54:3798–3805
von Noorden GK, Preziosi TJ (1966) Eye movement recordings in neurological disorders. Arch Ophthalmol 76:162–171
Fernandez-Duque D, Posner MI (2001) Brain imaging of attentional networks in normal and pathological states. J Clin Exp Neuropsychol 23:74–93
Coiner B et al (2019) Functional neuroanatomy of the human eye movement network: a review and atlas. Brain Struct Funct 224:2603–2617
Müri R, Cazzoli D, Nyffeler T (2019) Eye movements in neurology. In: Eye movement research. Springer, pp 749–774
MacAskill MR, Anderson TJ (2016) Eye movements in neurodegenerative diseases. Curr Opin Neurol 29:61–68
Molitor RJ, Ko PC, Ally BA (2015) Eye movements in Alzheimer’s disease. J Alzheimers Dis 44:1–12
Peltsch A, Hoffman A, Armstrong I, Pari G, Munoz D (2008) Saccadic impairments in Huntington’s disease. Exp Brain Res 186:457–469
Pinkhardt EH, Kassubek J (2011) Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord 17:223–230
RodrĂguez-Labrada R, Vázquez-Mojena Y, Velázquez-PĂ©rez L (2019) Eye movement abnormalities in neurodegenerative diseases. In: Mravicic, I. (editor), Eye Motility, London: IntechOpen, 1–17
Stuart S, Alcock L, Galna B, Lord S, Rochester L (2014) The measurement of visual sampling during real-world activity in Parkinson’s disease and healthy controls: a structured literature review. J Neurosci Methods 222:175–188
Stuart S, Galna B, Lord S, Rochester L, Godfrey A (2014) Quantifying saccades while walking: validity of a novel velocity-based algorithm for mobile eye tracking. In: 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE, 2014), pp 5739–5742
Noiret N, Vigneron B, Diogo M, Vandel P, Laurent É (2017) Saccadic eye movements: what do they tell us about aging cognition? Aging Neuropsychol Cognit 24:575–599
Mucha A et al (2014) A brief vestibular/ocular motor screening (VOMS) assessment to evaluate concussions: preliminary findings. Am J Sports Med 42:2479–2486
Yorke AM, Smith L, Babcock M, Alsalaheen B (2017) Validity and reliability of the vestibular/ocular motor screening and associations with common concussion screening tools. Sports Health 9:174–180
Conte L et al (2021) The eye-tracking technology in the healthcare settings: an observational, cross sectional, multicenter study. JDREAM 5:11–18
Tao L et al (2020) Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders. Neurol Sci 41:1697–1704
Li W, Zhou W, Fei M, Xu Y, Yang E (2020) Eye Tracking methodology for diagnosing neurological diseases: a survey. In: 2020 Chinese Automation Congress (CAC) (IEEE, 2020), pp 2158–2162
Yousef A et al (2019) Subclinical saccadic eye movement dysfunction in pediatric multiple sclerosis. J Child Neurol 34:38–43
Larrazabal AJ, Cena CG, MartĂnez CE (2019) Video-oculography eye tracking towards clinical applications: a review. Comput Biol Med 108:57–66
Stuart S, Galna B, Delicato LS, Lord S, Rochester L (2017) Direct and indirect effects of attention and visual function on gait impairment in Parkinson’s disease: influence of task and turning. Eur J Neurosci 46:1703–1716
Stuart S, Lord S, Galna B, Rochester L (2018) Saccade frequency response to visual cues during gait in Parkinson’s disease: the selective role of attention. Eur J Neurosci 47:769–778
Vitório R et al (2013) Influence of visual feedback sampling on obstacle crossing behavior in people with Parkinson’s disease. Gait Posture 38:330–334
Vitório R et al (2014) Visual cues and gait improvement in Parkinson’s disease: which piece of information is really important? Neuroscience 277:273–280
Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548–560
Armstrong RA (2017) Visual dysfunction in Parkinson’s disease. In: Chaudhuri KR, Titova N (eds) International review of neurobiology, vol 134. Academic Press, London, pp 921–946
Armstrong RA (2012) Visual signs and symptoms of dementia with Lewy bodies. Clin Exp Optom 95:621–630
Armstrong RA (2015) Oculo-visual dysfunction in Parkinson’s disease. J Parkinsons Dis 5:715–726
Kassubek J, Danek A, Greenlee M, Pinkhardt E (2013) The eye as a window to the pathophysiology in Parkinson’s syndromes. Nervenarzt 84:909–917
Antoniades CA, Demeyere N, Kennard C, Humphreys GW, Hu MT (2015) Antisaccades and executive dysfunction in early drug-naive Parkinson’s disease: the discovery study. Mov Disord 30:843–847
Mosimann UP et al (2005) Saccadic eye movement changes in Parkinson’s disease dementia and dementia with Lewy bodies. Brain 128:1267–1276
Pinkhardt EH et al (2012) Eye movement impairments in Parkinson’s disease: possible role of extradopaminergic mechanisms. BMC Neurol 12:1–8
Srivastava A et al (2014) Saccadic eye movements in Parkinson’s disease. Indian J Ophthalmol 62:538
Stuart S et al (2019) Pro-saccades predict cognitive decline in Parkinson’s disease: ICICLE-PD. Mov Disord 34:1690–1698
Wong OWH et al (2018) Eye movement parameters and cognitive functions in Parkinson’s disease patients without dementia. Parkinsonism Relat Disord 52:43–48
Pinkhardt EH et al (2009) Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease. J Neurol 256:1438–1446
White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA (1983) Ocular motor deficits in Parkinson’s disease: II. Control of the saccadic and smooth pursuit systems. Brain 106:571–587
Pretegiani E, Optican LM (2017) Eye movements in Parkinson’s disease and inherited parkinsonian syndromes. Front Neurol 8:592
de Boer C, van der Steen J, Mattace-Raso F, Boon AJW, Pel JJM (2016) The effect of neurodegeneration on visuomotor behavior in Alzheimer’s disease and Parkinson’s disease. Mot Control 20:1–20
Marx S et al (2012) Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci 6:88
Fukushima K, Fukushima J, Barnes GR (2017) Clinical application of eye movement tasks as an aid to understanding Parkinson’s disease pathophysiology. Exp Brain Res 235:1309–1321
Walker FO (2007) Huntington’s disease. Lancet 369:218–228
Roos RAC (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5:40
McColgan P, Tabrizi SJ (2018) Huntington’s disease: a clinical review. Eur J Neurol 25:24–34
Blekher T et al (2009) Visual scanning and cognitive performance in prediagnostic and early-stage Huntington’s disease. Mov Disord 24:533–540
Beenen N, Büttner U, Lange HW (1986) The diagnostic value of eye movement recording in patients with Huntington’s disease and their offspring. Electroencephalogr Clin Neurophysiol 63:119–127
Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington’s disease. Exp Brain Res 169:237–245
Lasker AG, Zee DS (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645
Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA (1983) Abnormal ocular motor control in Huntington’s disease. Neurology 33:1268
Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1987) Saccades in Huntington’s disease. Neurology 37:364
Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1988) Saccades in Huntington’s disease. Neurology 38:427
Klöppel S et al (2008) White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington’s disease. Brain 131:196–204
Thieben MJ et al (2002) The distribution of structural neuropathology in pre-clinical Huntington’s disease. Brain 125:1815–1828
Elahi FM, Miller BL (2017) A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13:457–476
Armstrong R, Kergoat H (2015) Oculo-visual changes and clinical considerations affecting older patients with dementia. Ophthalmic Physiol Opt 35:352–376
Pham TM et al (2018) Trends in dementia diagnosis rates in UK ethnic groups: analysis of UK primary care data. Clin Epidemiol 10:949–960
Weller J, Budson A (2018) Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res 7:F1000 Faculty Rev-1161
Anand A, Patience AA, Sharma N, Khurana N (2017) The present and future of pharmacotherapy of Alzheimer’s disease: a comprehensive review. Eur J Pharmacol 815:364–375
Hampel H et al (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain 141:1917–1933
Alosco ML et al (2018) A clinicopathological investigation of White matter hyperintensities and Alzheimer’s disease neuropathology. J Alzheimers Dis 63:1347–1360
Pereira MLG d F et al (2020) Saccadic eye movements associated with executive function decline in mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement 16:e040036
Shakespeare TJ et al (2015) Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy. Brain 138:1976–1991
Boxer AL et al (2012) Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease. Arch Neurol 69:509–517
Bylsma FW et al (1995) Changes in visual fixation and saccadic eye movements in Alzheimer’s disease. Int J Psychophysiol 19:33–40
Fernández G, Castro LR, Schumacher M, Agamennoni OE (2015) Diagnosis of mild Alzheimer disease through the analysis of eye movements during reading. J Integr Neurosci 14:121–133
Fernández G et al (2013) Eye movement alterations during reading in patients with early Alzheimer disease. Invest Ophthalmol Vis Sci 54:8345–8352
Kapoula Z et al (2014) Distinctive features of microsaccades in Alzheimer’s disease and in mild cognitive impairment. Age 36:535–543
Noiret N et al (2018) Saccadic eye movements and attentional control in Alzheimer’s disease. Arch Clin Neuropsychol 33:1–13
Yang Q, Wang T, Su N, Xiao S, Kapoula Z (2013) Specific saccade deficits in patients with Alzheimer’s disease at mild to moderate stage and in patients with amnestic mild cognitive impairment. Age 35:1287–1298
Freitas Pereira MLG, Camargo MVZA, Aprahamian I, Forlenza OV (2014) Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer’s disease. Neuropsychiatr Dis Treat 10:1273
McKeith IG et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88
Lippa CF et al (2007) DLB and PDD boundary issues. Neurology 68:812
Friedman JH (2018) Dementia with Lewy bodies and Parkinson disease dementia: it is the same disease! Parkinsonism Relat Disord 46:S6–S9
Surendranathan A et al (2020) Clinical diagnosis of Lewy body dementia. BJPsych Open 6:e61
Barber R, Panikkar A, McKeith IG (2001) Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry 16:S12–S18
Kapoula Z et al (2010) Spread deficits in initiation, speed and accuracy of horizontal and vertical automatic saccades in dementia with Lewy bodies. Front Neurol 1:138
Zoi K et al (2010) Preservation of automatic ocular saccades in healthy elderly: alteration in patients with dementia with Lewy body. Psychol Neuropsychiatr Vieil 8:295–306
Serra A, Chisari CG, Matta M (2018) Eye movement abnormalities in multiple sclerosis: pathogenesis, modeling, and treatment. Front Neurol 9:31
Olek MJ (2021) Multiple Sclerosis. Ann Intern Med 174:ITC81–ITC96
De Santi L et al (2011) Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study. Neurol Sci 32:67–71
Niestroy A, Rucker JC, Leigh RJ (2007) Neuro-ophthalmologic aspects of multiple sclerosis: using eye movements as a clinical and experimental tool. Clin Ophthalmol 1:267
Gil-Casas A, Piñero DP, Molina-Martin A (2020) Binocular, accommodative and oculomotor alterations in multiple sclerosis: a review. Semin Ophthalmol 35:103–115
Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S (2005) The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 4:111–121
Hoff JM, Dhayalan M, Midelfart A, Tharaldsen AR, Bø L (2019) Visual dysfunction in multiple sclerosis. Tidsskrift for Den norske legeforening. 2:139(11)
Ferreira MB et al (2018) Relationships between neuropsychological and antisaccade measures in multiple sclerosis patients. PeerJ 6:e5737
Bijvank JAN et al (2019) Quantification of visual fixation in multiple sclerosis. Invest Ophthalmol Vis Sci 60:1372–1383
Rempe T et al (2021) Quantification of smooth pursuit dysfunction in multiple sclerosis. Mult Scler Relat Disord 54:103073
Santinelli FB et al (2019) Saccadic eye movements are able to reduce body sway in mildly-affected people with multiple sclerosis. Mult Scler Relat Disord 30:63–68
Kuriakose D, Xiao Z (2020) Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci 21:7609
Murphy SJ, Werring DJ (2020) Stroke: causes and clinical features. Medicine 48(9):561–566
Famitafreshi H, Karimian M (2019) Overview of advances in the pathophysiology and treatment of stroke: a new plan for stroke treatment. Open Biol J 7:39–44
Pollock A, Hazelton C, Brady M (2011) Visual problems after stroke: a survey of current practice by occupational therapists working in UK stroke inpatient settings. Top Stroke Rehabil 18:643–651
Rowe F et al (2009) Visual impairment following stroke: do stroke patients require vision assessment? Age Ageing 38:188–193
Ciuffreda KJ (2007) Vision, perception, and cognition: a manual for the evaluation and treatment of the adult with acquired brain injury. LWW
Clisby C (1995) Visual assessment of patients with cerebrovascular accident on the elderly care wards. Br Orthopt J 52:38–40
Hepworth LR, Rowe FJ (2016) Visual impairment following stroke-the impact on quality of life: a systematic review. Ophthalmol Res 5:1–15
Bogousslavsky J, Meienberg O (1987) Eye-movement disorders in brain-stem and cerebellar stroke. Arch Neurol 44:141–148
Moncayo J, Bogousslavsky J (2012) Eye movement abnormalities. Manifestations of. Stroke 30:13–16
BRAZIS PW (1992) Ocular motor abnormalities in Wallenberg’s lateral medullary syndrome. In: Mayo Clinic proceedings, vol 67. Elsevier, pp 365–368
Brazinova A et al (2021) Epidemiology of traumatic brain injury in Europe: a living systematic review. J Neurotrauma 38:1411–1440
Dadas A, Washington J, Diaz-Arrastia R, Janigro D (2018) Biomarkers in traumatic brain injury (TBI): a review. Neuropsychiatr Dis Treat 14:2989
Graham NS, Sharp DJ (2019) Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia. J Neurol Neurosurg Psychiatry 90:1221–1233
Mayer AR, Quinn DK, Master CL (2017) The spectrum of mild traumatic brain injury: a review. Neurology 89:623–632
Lumba-Brown A et al (2018) Centers for disease control and prevention guideline on the diagnosis and management of mild traumatic brain injury among children. JAMA Pediatr 172:e182853–e182853
Armstrong RA (2018) Visual problems associated with traumatic brain injury. Clin Exp Optom 101:716–726
Kapoor N, Ciuffreda KJ (2002) Vision disturbances following traumatic brain injury. Curr Treat Options Neurol 4:271–280
Stuart S et al (2020) The measurement of eye movements in mild traumatic brain injury: a structured review of an emerging area. Front Sports Act Living 2:5
Hunfalvay M et al (2019) Horizontal and vertical self-paced saccades as a diagnostic marker of traumatic brain injury. Concussion 4:CNC60
Hunfalvay M et al (2020) Vertical smooth pursuit as a diagnostic marker of traumatic brain injury. Concussion 5:CNC69
Mani R, Asper L, Khuu SK (2018) Deficits in saccades and smooth-pursuit eye movements in adults with traumatic brain injury: a systematic review and meta-analysis. Brain Inj 32:1315–1336
Samadani U et al (2015) Eye tracking detects disconjugate eye movements associated with structural traumatic brain injury and concussion. J Neurotrauma 32:548–556
Snegireva N, Derman W, Patricios J, Welman K (2018) Eye tracking technology in sports-related concussion: a systematic review and meta-analysis. Physiol Meas 39:12TR01
Maruta J, Spielman LA, Rajashekar U, Ghajar J (2017) Visual tracking in development and aging. Front Neurol 8:640
Antoniades CA, Barker RA (2008) The search for biomarkers in Parkinson’s disease: a critical review. Expert Rev Neurother 8:1841–1852
Stuart S, Galna B, Lord S, Rochester L (2015) A protocol to examine vision and gait in Parkinson’s disease: impact of cognition and response to visual cues. F1000Res 4:1379
Hershey LA et al (1983) Saccadic latency measurements in dementia. Arch Neurol 40:592–593
Stuart S et al (2019) Validation of a velocity-based algorithm to quantify saccades during walking and turning in mild traumatic brain injury and healthy controls. Physiol Meas 40:044006
Andersson R, Larsson L, Holmqvist K, Stridh M, Nyström M (2017) One algorithm to rule them all? An evaluation and discussion of ten eye movement event-detection algorithms. Behav Res Methods 49:616–637
Stuart S et al (2019) Eye-tracker algorithms to detect saccades during static and dynamic tasks: a structured review. Physiol Meas 40:02TR01
Antoniades C et al (2013) An internationally standardised antisaccade protocol. Vis Res 84:1–5
Nij Bijvank J et al (2018) A standardized protocol for quantification of saccadic eye movements: DEMoNS. PLoS One 13:e0200695
Pelz JB, Canosa R (2001) Oculomotor behavior and perceptual strategies in complex tasks. Vis Res 41:3587–3596
Kasneci E, Black AA, Wood JM (2017) Eye-tracking as a tool to evaluate functional ability in everyday tasks in glaucoma. J Ophthalmol 2017:6425913
Stuart S et al (2018) Do you see what I see? Mobile eye-tracker contextual analysis and inter-rater reliability. Med Biol Eng Comput 56:289–296
Stuart S, Lord S, Hill E, Rochester L (2016) Gait in Parkinson’s disease: a visuo-cognitive challenge. Neurosci Biobehav Rev 62:76–88
Lohnes CA, Earhart GM (2011) Saccadic eye movements are related to turning performance in Parkinson disease. J Parkinsons Dis 1:109–118
Beck EN, Ehgoetz Martens KA, Almeida QJ (2015) Freezing of gait in Parkinson’s disease: an overload problem? PLoS One 10:e0144986
Hebert JR, Corboy JR, Vollmer T, Forster JE, Schenkman M (2018) Efficacy of balance and eye-movement exercises for persons with multiple sclerosis (BEEMS). Neurology 90:e797–e807
Kapoor N, Ciuffreda KJ, Han Y (2004) Oculomotor rehabilitation in acquired brain injury: a case series. Arch Phys Med Rehabil 85:1667–1678
Kapoor N, Ciuffreda KJ (2018) Assessment of neuro-optometric rehabilitation using the developmental eye movement (DEM) test in adults with acquired brain injury. J Opt 11:103–112
Simpson-Jones ME, Hunt AW (2019) Vision rehabilitation interventions following mild traumatic brain injury: a scoping review. Disabil Rehabil 41:2206–2222
Turton AJ et al (2015) Visual search training in occupational therapy–an example of expert practice in community-based stroke rehabilitation. Br J Occup Ther 78:674–687
Keane S, Turner C, Sherrington C, Beard JR (2006) Use of fresnel prism glasses to treat stroke patients with hemispatial neglect. Arch Phys Med Rehabil 87:1668–1672
Ha S-Y, Sung Y-H (2020) Effects of Fresnel prism glasses on balance and gait in stroke patients with hemiplegia: a randomized controlled trial pilot study. Technol Health Care 28:625–633
Alvarez TL et al (2021) Underlying neurological mechanisms associated with symptomatic convergence insufficiency. Sci Rep 11:1–10
Racette BA, Gokden M, Tychsen L, Perlmutter JS (1999) Convergence insufficiency in idiopathic Parkinson’s disease responsive to levodopa. Strabismus 7:169–174
DuPrey KM et al (2017) Convergence insufficiency identifies athletes at risk of prolonged recovery from sport-related concussion. Am J Sports Med 45:2388–2393
Convergence Insufficiency Treatment Trial (CITT) Study Group (2008) The convergence insufficiency treatment trial: design, methods, and baseline data. Ophthalmic Epidemiol 15:24–36
Lavrich JB (2010) Convergence insufficiency and its current treatment. Curr Opin Ophthalmol 21:356–360
Scheiman M et al (2002) A survey of treatment modalities for convergence insufficiency. Optom Vis Sci 79:151–157
Santo AL, Race ML, Teel EF (2020) Near point of convergence deficits and treatment following concussion: a systematic review. J Sport Rehabil 29:1179–1193
Acknowledgments
This research was supported by a Parkinson’s Foundation Postdoctoral Fellowship (PF-FBS-1898) and Clinical Research Award (PF-CRA-2073) (PI: Dr. Samuel Stuart). Additionally, this research was supported by an A1 Grant from the Private Physiotherapy Educational Foundation (PPEF - #368) (PI: Stuart). Julia Das was supported by a collaborative studentship between Northumbria University and Senaptec Inc., Lisa Graham was supported by a collaborative studentship between Northumbria University and Head Diagnostics.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Das, J. et al. (2022). Eye Movement in Neurological Disorders. In: Stuart, S. (eds) Eye Tracking. Neuromethods, vol 183. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2391-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2391-6_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2390-9
Online ISBN: 978-1-0716-2391-6
eBook Packages: Springer Protocols